机器人辅助肾部分切除术术前药物性静脉血栓栓塞预防的应用
该回顾性队列研究纳入2009至2020年945例机器人辅助肾部分切除术患者,比较术前单剂依诺肝素预防组(794例)与未预防组(151例)的30天出血及血栓事件。
要点
- 两组30天VTE事件、再入院及死亡率相似(均P>0.05)。
- 更长热缺血时间和大肿瘤尺寸是出血并发症的预测因素。
核心结论
- 术前单剂依诺肝素预防未显著改变机器人辅助肾部分切除术后的血栓和出血事件率。
研究设计与样本
- 回顾性队列研究,纳入2009至2020年945例机器人辅助肾部分切除术患者,其中794例(84%)接受术前依诺肝素预防,151例(16%)未接受。
主要发现
- 两组30天再入院、VTE事件和死亡率相似(均P>0.05)。
临床怎么用
- 术前单剂依诺肝素可用于机器人辅助肾部分切除术的VTE预防,未显著增加出血风险,但需结合患者个体血栓和出血风险权衡。
局限性
- 回顾性研究设计,组间基线特征存在显著差异(年龄、BMI、ASA分级、吸烟状态、热缺血时间),可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether a single dose of preoperative enoxaparin for venous thromboembolism (VTE) prophylaxis impacts rates of thrombotic and bleeding events after robotic partial nephrectomy (RPNx). METHODS: A retrospective cohort study of RPNx patients from 2009 to 2020 was performed. Clinical characteristics and perioperative outcomes were compared between patients receiving a single dose of preoperative enoxaparin and those who did not. The primary outcome was 30-day hemorrhagic complications (transfusion ≥2 units, embolization, or reoperation for bleeding). Secondary outcomes were 30-day VTE events. Multivariable logistic regression was performed to control for significant differences between groups and to identify predictors of hemorrhagic complications among patients. RESULTS: Among 945 RPNx procedures, 794 (84%) received preoperative enoxaparin (PPx) and 151 (16%) did not (NPPx). The PPx cohort was older (P = .004), had lower BMI (P = .03), lower ASA class (P = .049), and fewer smokers (P = .03). Warm ischemia time was longer for PPx patients (P < .001). 4.9% and 2.6% of the PPx and NPPx cohorts, respectively, developed postoperative hemorrhagic complications (P = .29). After adjustment for potential covariates, pharmacologic prophylaxis was not associated with 30-day hemorrhagic complications (P = .39). On multivariable regression, longer warm ischemia time (OR 1.05, 95% CI 1.01-1.10, P = .02) and greater tumor size (OR 1.27, 95% CI 1.03-1.56, P = .02) were predictors of hemorrhagic complications. 30-day readmissions, VTE events, and mortality were similar between groups (all P> 0.05). CONCLUSION: Similar rates of thrombotic and bleeding events occurred between patients receiving pharmacologic prophylaxis and those who did not. Single dose of preoperative enoxaparin did not significantly alter perioperative outcomes after RPNx.
引用
- Dai JC, Morgan TN, Kusin S, et al. Use of Pre-operative Pharmacologic Venous Thromboembolism Prophylaxis for Robotic Partial Nephrectomy. Urology. 2021. PMID: 33930459. doi:10.1016/j.urology.2021.03.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。